Pursuant to Regulation 30(2) read with Schedule III Part A Para A (15) of the Listing Regulations, Lupin has informed that the Company will be participating in Nuvama - Specialty Chemicals and Healthcare Investor Conference on June 25, 2025 (In person).
The above information is a part of company’s filings submitted to BSE.